Subtopic Deep Dive
Alternative Polyadenylation RNA Regulation
Research Guide
What is Alternative Polyadenylation RNA Regulation?
Alternative polyadenylation (APA) is a post-transcriptional process that generates mRNA isoforms with variable 3' untranslated region (3'UTR) lengths by selecting different polyadenylation sites, altering miRNA binding, mRNA stability, and protein expression.
APA dysregulates in cancer through CFIm25 depletion, shortening 3'UTRs of proliferation genes and evading repression in breast, lung, and prostate tumors (Masamha et al., 2014). Xia et al. (2014) mapped APA landscapes across seven tumor types using RNA-seq, revealing widespread 3'UTR shortening. Over 20 papers from 2011-2018 document APA's role in cancer transcriptomes.
Why It Matters
APA reprograms cancer transcriptomes by shortening 3'UTRs, enabling growth factor independence and metastasis; Masamha et al. (2014) showed CFIm25 links APA to glioblastoma suppression, with depletion promoting tumor growth. Xia et al. (2014) identified consistent 3'UTR shortening in seven tumor types, correlating with oncogenic signaling. Yue et al. (2018) connected m6A writer VIRMA to APA site choice, enhancing cancer progression via 3'UTR methylation near stop codons. Bell et al. (2012) detailed IGF2BPs stabilizing APA-regulated oncogene mRNAs in tumors.
Key Research Challenges
Quantifying APA isoform shifts
Distinguishing proximal vs. distal polyA sites in bulk RNA-seq requires specialized methods like PolyA-seq or PAS-Seq to avoid bias (Derti et al., 2012; Shepard et al., 2011). Tumor heterogeneity complicates isoform quantification across cancer types (Xia et al., 2014). Statistical models must account for cleavage site usage changes under CFIm25 depletion (Masamha et al., 2014).
Linking APA to miRNA evasion
Shortened 3'UTRs escape miRNA repression, but predicting affected sites needs integrated APA-miRNA binding models (Mayr, 2017). Cancer-specific APA patterns vary by tumor type, challenging generalization (Xia et al., 2014). Validating functional impacts requires reporter assays beyond sequencing data.
Targeting APA regulators in cancer
CFIm25 depletion drives oncogenic APA, but therapeutic restoration faces delivery and specificity issues (Masamha et al., 2014). VIRMA promotes cancer-linked APA, yet inhibitors must spare normal polyadenylation (Yue et al., 2018). Clinical translation needs biomarkers for APA dysregulation across tumors.
Essential Papers
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
Ying Yang, Phillip J. Hsu, Yusheng Chen et al. · 2018 · Cell Research · 1.7K citations
VIRMA mediates preferential m6A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation
Yanan Yue, Jun Liu, Xiaolong Cui et al. · 2018 · Cell Discovery · 934 citations
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Jessica L. Bell, Kristin Wächter, Britta Mühleck et al. · 2012 · Cellular and Molecular Life Sciences · 787 citations
The insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1, IGF2BP2, IGF2BP3) belong to a conserved family of RNA-binding, oncofetal proteins. Several studies have shown that these...
Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus
Jian‐Feng Xiang, Qing-Fei Yin, Tian Chen et al. · 2014 · Cell Research · 725 citations
The human 8q24 gene desert contains multiple enhancers that form tissue-specific long-range chromatin loops with the MYC oncogene, but how chromatin looping at the MYC locus is regulated remains po...
A quantitative atlas of polyadenylation in five mammals
Adnan Derti, Philip W. Garrett-Engele, Kenzie D. MacIsaac et al. · 2012 · Genome Research · 655 citations
We developed PolyA-seq, a strand-specific and quantitative method for high-throughput sequencing of 3′ ends of polyadenylated transcripts, and used it to globally map polyadenylation (polyA) sites ...
Ending the message: poly(A) signals then and now
Nicholas Proudfoot · 2011 · Genes & Development · 610 citations
Polyadenylation [poly(A)] signals (PAS) are a defining feature of eukaryotic protein-coding genes. The central sequence motif AAUAAA was identified in the mid-1970s and subsequently shown to requir...
Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types
Zheng Xia, Lawrence A. Donehower, Thomas A. Cooper et al. · 2014 · Nature Communications · 600 citations
Reading Guide
Foundational Papers
Start with Proudfoot (2011) for polyA signal mechanisms (610 citations), then Derti et al. (2012) PolyA-seq atlas (655 citations), followed by Masamha et al. (2014) CFIm25-cancer link and Xia et al. (2014) tumor landscapes to build APA basics before cancer applications.
Recent Advances
Study Yue et al. (2018) on VIRMA-m6A-APA (934 citations) and Mayr (2017) on 3'UTR regulation (571 citations) for epitranscriptomic integration and isoform impacts.
Core Methods
PolyA-seq (Derti et al., 2012), PAS-Seq (Shepard et al., 2011), RNA-seq APA quantification (Xia et al., 2014); core techniques include cleavage site usage indexing and 3'UTR length modeling.
How PapersFlow Helps You Research Alternative Polyadenylation RNA Regulation
Discover & Search
Research Agent uses searchPapers('alternative polyadenylation cancer CFIm25') to retrieve Masamha et al. (2014), then citationGraph reveals 458 citing papers on glioblastoma APA, while findSimilarPapers expands to Xia et al. (2014) tumor landscapes and exaSearch uncovers VIRMA-APA links from Yue et al. (2018).
Analyze & Verify
Analysis Agent applies readPaperContent on Masamha et al. (2014) to extract CFIm25 depletion data, verifyResponse with CoVe cross-checks APA claims against Xia et al. (2014), and runPythonAnalysis processes RNA-seq PolyA-seq data for 3'UTR length distributions using pandas, with GRADE scoring evidence strength for tumor-specific shifts.
Synthesize & Write
Synthesis Agent detects gaps in CFIm25 therapeutic targeting via contradiction flagging across Masamha (2014) and Yue (2018), while Writing Agent uses latexEditText for APA pathway diagrams, latexSyncCitations for 20+ papers, and latexCompile to generate a review manuscript with exportMermaid for polyA site selection flowcharts.
Use Cases
"Analyze 3'UTR shortening statistics from Xia et al. 2014 across tumor types"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas on RNA-seq data for PDU quantification) → matplotlib plots of proximal/distal site usage shifts.
"Draft LaTeX figure of CFIm25-APA pathway in glioblastoma"
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (APA cascade) → latexSyncCitations (Masamha 2014) → latexCompile → PDF with TikZ diagram.
"Find code for PolyA-seq analysis from Derti et al. 2012"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → exportCsv of polyA site pipelines for 3'UTR isoform quantification.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ APA-cancer papers starting with citationGraph on Masamha (2014), generating structured report on 3'UTR shortening patterns. DeepScan applies 7-step analysis with CoVe checkpoints to verify VIRMA-APA links from Yue (2018) against tumor datasets. Theorizer generates hypotheses on CFIm25 restoration therapies from Xia (2014) landscapes.
Frequently Asked Questions
What defines alternative polyadenylation in cancer?
APA selects different polyA sites, shortening 3'UTRs to evade miRNA repression; CFIm25 depletion drives this in tumors (Masamha et al., 2014).
What methods map APA sites?
PolyA-seq quantitatively maps polyA sites across tissues (Derti et al., 2012); PAS-Seq reveals dynamic landscapes (Shepard et al., 2011); RNA-seq analyzes APA in tumors (Xia et al., 2014).
What are key papers on APA-cancer links?
Masamha et al. (2014, Nature, 458 citations) links CFIm25 to glioblastoma; Xia et al. (2014, Nature Communications, 600 citations) maps seven tumor types; Yue et al. (2018) ties VIRMA to 3'UTR APA.
What open problems remain in APA regulation?
Therapeutic targeting of CFIm25/VIRMA without disrupting normal polyadenylation; predicting cancer-specific miRNA evasion from APA shifts; integrating APA with m6A epitranscriptomics.
Research RNA modifications and cancer with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Alternative Polyadenylation RNA Regulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the RNA modifications and cancer Research Guide